DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Läubli H, Müller P, D'Amico L. et al.
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.
Cancer Immunol Immunther 2018;
67: 815-824
DOI: 10.1007/s00262-018-2136-x. (PMID: 29487979)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.